1 not yet recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow GBA1 Parkinson Disease: new trials by email Literature Review of GBA1 Parkinson Disease trials Research Report on GBA1 Parkinson Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging brain imaging, blood draw, Skin biopsy - Parkinson's Disease (PD), GBA1 Parkinson Disease | Not applicable | Not yet recruiting | University of Pavia | 160 | 2026-05-11 | 2026-05-01 |
| A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease gene therapy - GBA1 Parkinson Disease | Phase 1 / Phase 2 | Withdrawn | Capsida Biotherapeutics, Inc. | 2025-08-18 | 2026-06-22 |
Parkinson Disease (2) · Mitochondrial Diseases (1) · REM Sleep Behavior Disorder (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Parkinsonian Disorders (2) · Synucleinopathies (2) · Mental Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Parasomnias (1) · REM Sleep Parasomnias (1) · Sleep Wake Disorders (1)
Blood Specimen Collection (1) · Genetic Therapy (1) · Neuroimaging (1)
Capsida Biotherapeutics, Inc. (1) · University of Pavia (1)
Italy (1) · United States (1)